Summary
Healthcare analyst with 12+ years’ experience in both sell-side and buy-side leadership roles, with extensive experience IPO experience and a robust network of institutional investors and corporate executives. Coverage spans biopharma, biotech, CROs, devices, and health-tech stocks, delivered through with stock/sector/thematic reports, detailed financial models, and direct corporate access.
Areas of Expertise
Primary Asset Class:
Equities
Geography:
Asia Pacific
Countries:
(generalist)
Sectors:
Health Care
Content Verticals:
Equity Bottom-Up, Thematic (Sector/Industry)
Work Experience:
- Daiwa Capital Markets - Head of China Healthcare
- Macquarie - Head of China Healthcare
- Mirae
- Bank of China International